Neoadjuvant chemotherapy equalizes the optimal cytoreduction rate to primary surgery without improving survival in advanced ovarian cancer

被引：0
作者：
Salih Taşkın
Mete Güngör
Fırat Ortaç
Derya Öztuna
机构：
[1] Medical School of Ankara University,Department of Obstetrics and Gynecology
[2] Medical School of Acıbadem University,Department of Obstetrics and Gynecology
[3] Medical School of Ankara University,Department of Biostatistics
[4] Ankara Üniversitesi Tıp Fakültesi,Kadın Hastalıkları ve Doğum Anabilim Dalı
来源：
Archives of Gynecology and Obstetrics | 2013年 / 288卷
关键词：
Neoadjuvant chemotherapy; Ovarian cancer; Optimal cytoreduction; Survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1399 / 1403
页数：4
相关论文
共 64 条
  • [1] Chang SJ(2012)Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer Ann Surg Oncol 19 4059-4067
  • [2] Bristow RE(2011)Optimal primary surgical treatment for advanced epithelial ovarian cancer Cochrane Database Syst Rev 8 CD007565-2320
  • [3] Ryu HS(2009)Does Neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? meta-analysis of 21 Studies Ann Surg Oncol 16 2315-1076
  • [4] Elattar A(2006)Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis Gynecol Oncol 103 1070-470
  • [5] Bryant A(2001)Neoadjuvant chemotherapy or primary surgery in advanced epithelial ovarian carcinoma Int J Gynecol Cancer 11 466-396
  • [6] Winter-Roach BA(1996)Neoadjuvant chemotherapy in advanced ovarian cancer Eur J Gynaecol Oncol 17 393-99
  • [7] Hatem M(1999)Neoadjuvant chemotherapy for advanced ovarian cancer: long-term survival Gynecol Oncol 72 93-2591
  • [8] Naik R(2001)Neoadjuvant chemotherapy followed by tumor debulking prolongs survival for patients with poor prognosis in International Federation of Gynecology and Obstetrics Stage IIIC ovarian carcinoma Cancer 92 2585-150
  • [9] Kang S(1991)Neoadjuvant chemotherapy and interval debulking for advanced epithelial ovarian cancer Gynecol Oncol 42 146-953
  • [10] Nam BH(2010)European organization for research and treatment of cancer-gynaecological cancer group; NCIC clinical trials group N Engl J Med 363 943-217
1234567